Who
Marshall H. Woodworth
Chief Financial Officer
Company insider
Files Form 4 as: Chief Financial Officer, MetaVia; Chief Financial Officer, Furiex Pharmaceuticals.
In numbers
- Trades disclosed
- 12
- Buys
- 2
- Sells
- 0
- Bought
- $102K
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 17 Jun 2010
- Last trade
- 23 Jan 2026
- Last filed
- 27 Jan 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 23 Jan 2026filed 27 Jan 2026 | MTVA MetaViaBiotechnology | SEC FORM 4 Code A | —28,000 at $0.00 | filing |
| 23 Jan 2026filed 27 Jan 2026 | MTVA MetaViaBiotechnology | SEC FORM 4 Code A | —28,000 at $0.00 | filing |
| 12 Aug 2025filed 13 Aug 2025 | MTVA MetaViaBiotechnology | SEC FORM 4 Code G | —14,200 at $0.00 | filing |
| 4 Jun 2025filed 4 Jun 2025 | MTVA MetaViaBiotechnology | SEC FORM 4 Bought | $9,94014,200 at $0.70 | filing |
| 1 Mar 2025filed 4 Mar 2025 | MTVA MetaViaBiotechnology | SEC FORM 4 Code F | $4,9893,417 at $1.46 | filing |
| 1 Mar 2024filed 4 Mar 2024 | MTVA MetaViaBiotechnology | SEC FORM 4 Code A | —33,496 at $0.00 | filing |
| 10 Jun 2013filed 12 Jun 2013 | Furiex Pharmaceuticals | SEC FORM 4 Code A | —10,200 at $0.00 | filing |
| 24 Feb 2012filed 11 Apr 2012 | Furiex Pharmaceuticalsoption or derivative | SEC FORM 4 Code A | —8,294 at $0.00 | filing |
| 4 Nov 2011filed 8 Nov 2011 | Furiex Pharmaceuticals | SEC FORM 4 Bought | $92K6,211 at $14.78 | filing |
| 3 Oct 2011filed 5 Oct 2011 | Furiex Pharmaceuticalsoption or derivative | SEC FORM 4 Code A | —29,644 at $0.00 | filing |
| 9 May 2011filed 11 May 2011 | Furiex Pharmaceuticalsoption or derivative | SEC FORM 4 Code A | —26,000 at $0.00 | filing |
| 17 Jun 2010filed 21 Jun 2010 | Furiex Pharmaceuticalsoption or derivative | SEC FORM 4 Code A | —49,407 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.